Brief: 180 Life Sciences Expands Scientific Fibrosis Platform With Collagen Vi As A Driver And Disease Biomarker In Human Fibrosis Published In The Febs Journal

Forum Markets,

07/07/2021 13:13

July 7 (Reuters) - 180 Life Sciences Corp  ATNF.O :
    * 180 LIFE SCIENCES EXPANDS SCIENTIFIC FIBROSIS PLATFORM
WITH
COLLAGEN VI AS A DRIVER AND DISEASE BIOMARKER IN HUMAN FIBROSIS
PUBLISHED IN THE FEBS JOURNAL

Source text for Eikon:  ID:nGNX1wKzYF 
Further company coverage:  ATNF.O 

 ((Reuters.Briefs@thomsonreuters.com;))